About OneAlphaMed : India's Pharma Marketing Agency

OneAlphaMed brings together three capabilities that most agencies keep separate: pre-launch brand strategy, scientific medical affairs, and proprietary AI technology that drives customized solutions. This means a pharmaceutical brand working with OneAlphaMed gets its launch roadmap, KOL engagement program, publication strategy, and bespoke, AI-driven HCP digital tools developed by one aligned team rather than three separate vendors. The agency also operates a verified directory of over 5,000 Indian and international KOLs, which gives brands direct access to credible expert networks without a procurement delay.

OneAlphaMed has deep experience across cardiology, respiratory, endocrinology, oncology, neurology, and metabolic health. The agency has designed and delivered medical education programs, KOL advisory boards, disease awareness campaigns, and patient support programs across all of these therapeutic areas in India and international markets. The agency’s KOL network covers specialists across 35 countries and can be activated for therapy areas beyond its primary focus.

Regulatory compliance is embedded into every deliverable OneAlphaMed produces. All medical communications assets are developed in line with applicable standards including FDA OPDP, EFPIA, and UCPMP guidelines depending on the market.

OneAlphaMed designs and manages Patient advocacy and support services that address the full range of barriers between a patient and their therapy. This includes omnichannel patient support across phone, mobile, and digital channels, and bridge program management. The agency also produces health literacy materials including Plain Language Summaries and culturally adapted patient education content for Indian and global markets.